CD40 ligand is required for protective cell-mediated immunity to Leishmania major

Immunity

Volumn 4, Issue 3, 1996, Pages 283-289

  Campbell, Kim A ^a   Ovendale, Pamela J ^b   Kennedy, Mary K ^a   Fanslow, William C ^a   Reed, Steven G ^b   Maliszewski, Charles R ^a  

^a AMGEN INC   (United States)

^b INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ETIOLOGY; IMMUNOREGULATION; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029965957     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80436-7     Document Type: Article

References (48)

1. Armitage, R.J., Fanslow, W.C., Strockbine, L., Sato, T.A., Clifford, K.N., Macduff, B.M., Anderson, D.M., Gimpel, S.D., Davis-Smith, T., Maliszewski, C.R., Clark, E.A., Smith, C.A., Grabstein, K.H., Cosman, D., and Spriggs, M.K. (1992). Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80-82.
2. Armitage, R.J., Tough, T.W., Macduff, B.M., Fanslow, W.C., Spriggs, M.K., Ramsdell, F., and Alderson, M.R. (1993). CD40 ligand is a T cell growth factor. Eur. J. Immunol. 23, 2326-2331.
3. Banchereau, J., Bazan, F., Blanchard, D., Brière, F., Galizzi, J.P., van Kooten, C., Liu, Y.J., Rousset, F., and Saeland, S. (1994). The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922.
4. Belosevic, M., Finbloom, D.S., Van Der Meide, P.M., Slayter, M.V., and Nacy, C.A. (1989). Administration of monoclonal anti-IFNγ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143, 266-274.
5. Buhlmann, J.E., Foy, T.M., Aruffo, A., Crassi, K.M., Ledbetter, J.A., Green, W.R., Xu, J.C., Shultz, L.D., Roopesian, D., Flavell, R.A., Fast, L., Noelle, R.J., and Durie, F.H. (1995). In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2, 645-653.
6. Callard, R.E., Armitage, R.J., Fanslow, W.C., and Spriggs, M.K. (1993). CD40 ligand and its role in X-linked hyper-IgM syndrome, Immunol. Today 14, 559-564.
7. Dighe, A.S., Campbell, D., Hsieh, C.-S., Clarke, S., Greaves, D.R., Gordon, S., Murphy, K.M., and Schreiber, R.D. (1995). Tissue-specific targeting of cytokine unresponsiveness in transgenic mice. Immunity 3, 657-666.
8. Ding, A.H., Nathan, C.F., and Stuehr, D.J. (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141, 2407-2412.
9. Durie, F.H., Aruffo, A., Ledbetter, J., Crassi, K.M., Green, W.R., Fast, L.D., and Noelle, R.J. (1994). Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94, 1333-1338.
10. Fanslow, W.C., Srinivasan, S., Paxton, R., Gibson, M.G., Spriggs, M.K., and Armitage, R.J. (1994). Structural characteristics of CD40 ligand that determine biological function. Sem. Immunol. 6, 267-278.
11. Flesch, I.E.A., Hess, J.H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H., and Kaufmann, S.H.E. (1995). Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J. Exp. Med. 181, 1615-1621.
12. Foy, T.M., Shepherd, D.M., Durie, F.H., Aruffo, A., Ledbetter, J.A., and Noelle, R.J. (1993). In vivo CD40-gp39 interactions are essential forthymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178, 1567-1575.
13. Gazzinelli, R.T., Hieny, S., Wynn, T.A., Wolf, S., and Sher, A. (1993). Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90, 6115-6119.
14. Gazzinelli, R.T., Wysocka, M., Hayashi, S., Denkers, E.Y., Hieny, S., Caspar, P., Trinchieri, G., and Sher, A. (1994). Parasite-induced IL-12 stimulates early IFNγ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153, 2533-2543.
15. Hayes, M.P., Wang, J., and Norcross, M.A. (1995). Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood 86, 646-650.
16. Heinzel, F.P., Sadick, M.D., Holaday, B.J., Coffman, R.L., and Locksley, R.M. (1989). Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169, 59-72.
17. Heinzel, F.P., Schoenhaut, D.S., Rerko, R.M., Rosser, L.E., and Gately, M.K. (1993). Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509.
18. Heinzel, F.P., Rerko, R.M., Ahmed, P., and Pearlman, E. (1995). Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155, 730-739.
19. Holaday, B. J., Sadick, M.D., Wang, Z.-E., Reiner, S.L., Heinzel, F.P., Parslow, T.G., and Locksley, R.M. (1991). Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J. Immunol. 147, 1653-1658.
20. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.
21. Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., and Kikutani, H. (1994). The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178.
22. Kennedy, M.K., Picha, K.S., Shanebeck, K.D., Anderson, D.M., and Grabstein, K.H. (1994). Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones. Eur. J. Immunol. 24, 2271-2278.
23. Kennedy, M.K., Picha, K.S., Fanslow, W.C., Grabstein, K.H., Alderson, M.R., Clifford, K.N., Chin, W.A., and Mohler, K.M. (1996). CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol., in press.
24. Lane, P., Traunecker, A., Hubele, S., Inui, S., Lanzavecchia, A., and Gray, D. (1992). Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol. 22, 2573-2578.
25. Locksley, R.M. (1993). Interleukin 12 in host defense against microbial pathogens. Proc. Natl. Acad. Sci. USA 90, 5879-5880.
26. + T cells from αβ TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFNγ production is IFNγ-dependent. Int. Immunol. 5, 1119-1128.
27. Morris, L., Troutt, A.B., McLeod, K.S., Kelso, A., Handman, E., and Aebischer, T. (1993). Interleukin-4 but not gamma Interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect. Immun. 61, 3459-3465.
28. Murphy, E.E., Terres, G., Macatonia, S.E., Hsieh, C.-S., Mattson, J., Lanier, L., Wysocka, M., Trinchieri, G., Murphy, K., and O'Garra, A. (1994). B7 and interleukin 12 cooperate for proliferation and interferon γ production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180, 223-231.
29. Notarangelo, L.D., Duse, M., and Ugazio, A.G. (1992). Immunodeficiency with hyper-IgM (HIM), Immunodef. Rev. 3, 101-121.
30. Parker, D.C., Greiner, D.L., Phillips, N.E., Appel, M.C., Steele, A.W., Durie, F.H., Noelle, R.J., Mordes, J.P., and Rossini, A.A. (1995). Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92, 9560-9564.
31. Reed, S.G., Badaro, R., Masur, H., Carvalho, E.M., Lorenco, R., Lisboa, A., Teixeira, R., Johnson, W.D., Jr., and Jones, T.C. (1986). Selection of a skin test antigen for American visceral leishmaniasis. Am. J. Trop. Med. Hyg. 35, 79-85.
32. Reiner, S.L., and Locksley, R.M. (1995). The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13, 151-177.
33. + T cells during initiation of infection. J. Exp. Med. 179, 447-456.
34. Renshaw, B., Fanslow, W.C., III, Armitage, R.J., Campbell, K.A., Liggitt, D., Wright, B., Davison, B., and Maliszewski, C.R. (1994). Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180, 1889-1900.
35. Sadick, M.D., Locksley, R.M., Tubbs, C., and Raff, H.V. (1986). Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-γ in response to Leishmania antigens in vitro. J. Immunol. 136, 655-661.
36. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178, 567-577.
37. Scharton-Kersten, T., and Scott, P. (1995). The role of the innate immune response in Th1 cell development following Leishmania major infection. J. Leukoc. Biol. 57, 515-522.
38. Scharton-Kersten, T., Afonso, L.C.C., Wysocka, M., Trinchieri, G., and Scott, P. (1995). IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154, 5320-5330.
39. Scott, P., Natovitz, P., Coffman, R.L., Pearce, E., and Sher, A. (1988). Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168, 1675-1684.
40. Seder, R.A., Gazzinelli, R., Sher, A., and Paul, W.E. (1993). Interleukin 12 acts directly on CD4 T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90, 10188-10192.
41. Shu, U., Kiniwa, M., Wu, C.Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M., and Delespesse, G. (1995). Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25, 1125-1128.
42. Skeiky, Y.A.W., Guderian, J.A., Benson, D.R., Bacelar, O., Carvalho, E.M., Kubin, M., Badaro, R., Trinchieri, G., and Reed, S.G. (1995). A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1 -type cytokine profile and to produce interleukin 12. J. Exp. Med. 181, 1527-1537.
43. Spriggs, M.K., Armitage, R.J., Strockbine, L., Clifford, K.N., Macduff, B.M., Sato, T.A., Maliszewski, C.R., and Fanslow, W.C. (1992). Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176, 1543-1550.
44. Stout, R.D., Suttles, J., Xu, J., Grewal, I.S., and Flavell, R.A. (1996). Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156, 8-11.
45. Tian, L., Noelle, R.J., and Lawrence, D.A. (1995). Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur. J. Immunol. 25, 306-309.
46. van Essen, D., Kikutani, H., and Gray, D. (1995). CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378, 620-622.
47. Wiley, J.A., and Harmsen, A.G. (1995). CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155, 3525-3529.
48. Xu, J., Foy, T.M., Laman, J.D., Elliott, E.A., Dunn, J.J., Waldschmidt, T. J., Elsemore, J., Noelle, R.J., and Flavell, R.A. (1994). Mice deficient for the CD40 ligand. Immunity 1, 423-431.